The SR protein SC35 is responsible for aberrant splicing of the E1α pyruvate dehydrogenase mRNA in a case of mental retardation with lactic acidosis

被引:51
作者
Gabut, M
Miné, M
Marsac, U
Brivet, M
Tazi, J
Soret, J
机构
[1] UNII, CNRS, IFR122, UMR 5535,Inst Genet Mol Montpellier, F-34293 Montpellier, France
[2] Fac Med Necker Enfants Malad, Ctr Rech Therapeut Ophtalmol, Paris, France
[3] Hop Bicetre, Le Kremlin Bicetre, France
关键词
D O I
10.1128/MCB.25.8.3286-3294.2005
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Pyruvate dehydrogenase (PDH) complex deficiency is a major cause of lactic acidosis and Leigh's encephalomyelopathies in infancy and childhood, resulting in early death in the majority of patients. Most of the molecular defects have been localized in the coding regions of the E1 alpha PDH gene. Recently, we identified a novel mutation of the E1 alpha PDH gene in a patient with an encephalopathy and lactic acidosis. This mutation, located downstream of exon 7, activates a cryptic splice donor and leads to the retention of intronic sequences. Here, we demonstrate that the mutation results in an increased binding of the SR protein SC35. Consistently, ectopic overexpression of this splicing factor enhanced the use of the cryptic splice site, whereas small interfering RNA-mediated reduction of the SC35 protein levels in primary fibroblasts from the patient resulted in the almost complete disappearance of the aberrantly spliced E1 alpha PDH mRNA. Our findings open the exciting prospect for a novel therapy of an inherited disease by altering the level of a specific splicing factor.
引用
收藏
页码:3286 / 3294
页数:9
相关论文
共 46 条
[1]   A conserved Drosophila transportin-serine/arginine-rich (SR) protein permits nuclear import of Drosophila SR protein splicing factors and their antagonist repressor splicing factor 1 [J].
Allemand, E ;
Dokudovskaya, S ;
Bordonné, R ;
Tazi, J .
MOLECULAR BIOLOGY OF THE CELL, 2002, 13 (07) :2436-2447
[2]   Exonic splicing enhancers: mechanism of action, diversity and role in human genetic diseases [J].
Blencowe, BJ .
TRENDS IN BIOCHEMICAL SCIENCES, 2000, 25 (03) :106-110
[3]   PYRUVATE-DEHYDROGENASE DEFICIENCY [J].
BROWN, GK ;
OTERO, LJ ;
LEGRIS, M ;
BROWN, RM .
JOURNAL OF MEDICAL GENETICS, 1994, 31 (11) :875-879
[4]   hnRNP A/B proteins are required for inhibition of HIV-1 pre-mRNA splicing [J].
Caputi, M ;
Mayeda, A ;
Krainer, AR ;
Zahler, AM .
EMBO JOURNAL, 1999, 18 (14) :4060-4067
[5]  
Cardozo AK, 2000, PEDIATR RES, V48, P748
[6]   Listening to silence and understanding nonsense: Exonic mutations that affect splicing [J].
Cartegni, L ;
Chew, SL ;
Krainer, AR .
NATURE REVIEWS GENETICS, 2002, 3 (04) :285-298
[7]   Correction of disease-associated exon skipping by synthetic exon-specific activators [J].
Cartegni, L ;
Krainer, AR .
NATURE STRUCTURAL BIOLOGY, 2003, 10 (02) :120-125
[8]   Disruption of an SF2/ASF-dependent exonic splicing enhancer in SMN2 causes spinal muscular atrophy in the absence of SMN1 [J].
Cartegni, L ;
Krainer, AR .
NATURE GENETICS, 2002, 30 (04) :377-384
[9]   ESEfinder: a web resource to identify exonic splicing enhancers [J].
Cartegni, L ;
Wang, JH ;
Zhu, ZW ;
Zhang, MQ ;
Krainer, AR .
NUCLEIC ACIDS RESEARCH, 2003, 31 (13) :3568-3571
[10]  
CHUN K, 1995, AM J HUM GENET, V56, P558